Additionally, ESTIMATE analysis demonstrated negative correlations between TIGD1 expression and immune microenvironment scores—stromal scores, immune scores, and estimate scores—in multiple cancers (33 out of 39 cancers), suggesting its role in tumor immunity regulation (Figure 7b–d). Here, TIGD1 is linked to neoplasm.